AG˹ٷ

STOCK TITAN

[8-K] Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Perma-Fix Environmental Services, Inc. (PESI) has disclosed an insider transaction via SEC Form 4. On 07/01/2025, company director Zach Paul Wamp acquired 1,153 shares of common stock at $7.89 each. The purchase lifts his direct holdings to 49,365 shares. No dispositions, derivative securities, or 10b5-1 plan indications were reported.

While the dollar value of the trade is modest, the action marginally increases board-level exposure to the stock and can be interpreted as a signal of incremental insider confidence.

Perma-Fix Environmental Services, Inc. (PESI) ha comunicato una transazione interna tramite il modulo Form 4 della SEC. Il 01/07/2025, il direttore della società Zach Paul Wamp ha acquistato 1.153 azioni ordinarie al prezzo di $7,89 ciascuna. Questo acquisto porta la sua partecipazione diretta a 49.365 azioni. Non sono state segnalate cessioni, strumenti derivati o piani 10b5-1.

Nonostante il valore in dollari dell’operazione sia contenuto, l’azione aumenta leggermente l’esposizione del consiglio di amministrazione verso il titolo e può essere interpretata come un segnale di crescente fiducia da parte dell’insider.

Perma-Fix Environmental Services, Inc. (PESI) ha revelado una transacción de un insider mediante el Formulario 4 de la SEC. El 01/07/2025, el director de la empresa Zach Paul Wamp ܾó 1,153 acciones comunes a $7.89 cada una. Esta compra eleva su participación directa a 49,365 acciones. No se reportaron disposiciones, valores derivados ni indicaciones de planes 10b5-1.

Aunque el valor en dólares de la operación es modesto, esta acción incrementa ligeramente la exposición del consejo al título y puede interpretarse como una señal de confianza interna creciente.

Perma-Fix Environmental Services, Inc. (PESI)� SEC Form 4� 통해 내부� 거래� 공시했습니다. 2025� 7� 1�, 회사 이사 Zach Paul Wamp가 보통� 1,153�� 주당 $7.89� 매수했습니다. � 거래� 그의 직접 보유 주식은 49,365�가 되었습니�. 처분, 파생 증권 또는 10b5-1 계획 관� 보고� 없었습니�.

거래 금액은 크지 않지�, � 행동은 이사� 차원� 주식 노출� 다소 증가시키� 내부자의 신뢰가 점진적으� 높아지� 있음� 나타내는 신호� 해석� � 있습니다.

Perma-Fix Environmental Services, Inc. (PESI) a déclaré une transaction d'initié via le Formulaire 4 de la SEC. Le 01/07/2025, le directeur de l'entreprise Zach Paul Wamp a acquis 1 153 actions ordinaires au prix de 7,89 $ chacune. Cet achat porte sa détention directe à 49 365 actions. Aucune cession, valeur dérivée ou indication de plan 10b5-1 n’a été signalée.

Bien que la valeur monétaire de la transaction soit modeste, cette action augmente légèrement l’exposition du conseil d’administration au titre et peut être interprétée comme un signe de confiance croissante de la part de l’initié.

Perma-Fix Environmental Services, Inc. (PESI) hat eine Insider-Transaktion über das SEC Formular 4 offengelegt. Am 01.07.2025 erwarb der Unternehmensdirektor Zach Paul Wamp 1.153 Aktien des Stammaktienkapitals zum Preis von $7,89 pro Aktie. Der Kauf erhöht seinen direkten Anteil auf 49.365 Aktien. Es wurden keine Veräußerungen, derivativen Wertpapiere oder 10b5-1-Pläne gemeldet.

Obwohl der Geldwert der Transaktion gering ist, erhöht die Aktion leicht die Exponierung des Vorstands gegenüber der Aktie und kann als Signal für ein wachsendes Insider-Vertrauen interpretiert werden.

Positive
  • Director insider purchase: Zach Wamp bought 1,153 PESI shares at $7.89, increasing his direct stake to 49,365 shares, signaling modest insider confidence.
Negative
  • Limited scale: The purchase is small relative to both Wamp’s existing holdings and PESI’s share count, so the informational value is modest.

Insights

TL;DR: Small insider buy—slightly positive sentiment, limited financial impact.

The acquisition adds roughly $9,100 of stock based on the reported price, a negligible amount versus PESI’s market capitalization. Nevertheless, insider purchases are generally viewed favorably because they align management incentives with shareholders. The absence of sales or derivative hedges suggests an unhedged commitment, albeit small. From a trading perspective, the event is not materially impactful but may offer a marginal confidence boost to investors tracking insider activity.

Perma-Fix Environmental Services, Inc. (PESI) ha comunicato una transazione interna tramite il modulo Form 4 della SEC. Il 01/07/2025, il direttore della società Zach Paul Wamp ha acquistato 1.153 azioni ordinarie al prezzo di $7,89 ciascuna. Questo acquisto porta la sua partecipazione diretta a 49.365 azioni. Non sono state segnalate cessioni, strumenti derivati o piani 10b5-1.

Nonostante il valore in dollari dell’operazione sia contenuto, l’azione aumenta leggermente l’esposizione del consiglio di amministrazione verso il titolo e può essere interpretata come un segnale di crescente fiducia da parte dell’insider.

Perma-Fix Environmental Services, Inc. (PESI) ha revelado una transacción de un insider mediante el Formulario 4 de la SEC. El 01/07/2025, el director de la empresa Zach Paul Wamp ܾó 1,153 acciones comunes a $7.89 cada una. Esta compra eleva su participación directa a 49,365 acciones. No se reportaron disposiciones, valores derivados ni indicaciones de planes 10b5-1.

Aunque el valor en dólares de la operación es modesto, esta acción incrementa ligeramente la exposición del consejo al título y puede interpretarse como una señal de confianza interna creciente.

Perma-Fix Environmental Services, Inc. (PESI)� SEC Form 4� 통해 내부� 거래� 공시했습니다. 2025� 7� 1�, 회사 이사 Zach Paul Wamp가 보통� 1,153�� 주당 $7.89� 매수했습니다. � 거래� 그의 직접 보유 주식은 49,365�가 되었습니�. 처분, 파생 증권 또는 10b5-1 계획 관� 보고� 없었습니�.

거래 금액은 크지 않지�, � 행동은 이사� 차원� 주식 노출� 다소 증가시키� 내부자의 신뢰가 점진적으� 높아지� 있음� 나타내는 신호� 해석� � 있습니다.

Perma-Fix Environmental Services, Inc. (PESI) a déclaré une transaction d'initié via le Formulaire 4 de la SEC. Le 01/07/2025, le directeur de l'entreprise Zach Paul Wamp a acquis 1 153 actions ordinaires au prix de 7,89 $ chacune. Cet achat porte sa détention directe à 49 365 actions. Aucune cession, valeur dérivée ou indication de plan 10b5-1 n’a été signalée.

Bien que la valeur monétaire de la transaction soit modeste, cette action augmente légèrement l’exposition du conseil d’administration au titre et peut être interprétée comme un signe de confiance croissante de la part de l’initié.

Perma-Fix Environmental Services, Inc. (PESI) hat eine Insider-Transaktion über das SEC Formular 4 offengelegt. Am 01.07.2025 erwarb der Unternehmensdirektor Zach Paul Wamp 1.153 Aktien des Stammaktienkapitals zum Preis von $7,89 pro Aktie. Der Kauf erhöht seinen direkten Anteil auf 49.365 Aktien. Es wurden keine Veräußerungen, derivativen Wertpapiere oder 10b5-1-Pläne gemeldet.

Obwohl der Geldwert der Transaktion gering ist, erhöht die Aktion leicht die Exponierung des Vorstands gegenüber der Aktie und kann als Signal für ein wachsendes Insider-Vertrauen interpretiert werden.

false --12-31 0001130166 0001130166 2025-07-02 2025-07-02 0001130166 CYCC:CommonStockParValue0.001PerShareMember 2025-07-02 2025-07-02 0001130166 CYCC:PreferredStock0.001ParValueMember 2025-07-02 2025-07-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

July 2, 2025

Date of Report (date of earliest event reported)

 

 

Cyclacel Pharmaceuticals, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware   0-50626   91-1707622
(State or other jurisdiction of
incorporation or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

 

Level 10, Tower 11, Avenue 5, No. 8

Jalan Kerinchi, Kuala Lumpur, Malaysia 592000

(Address of principal executive offices) (Zip code)

 

(908) 517-7330

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   CYCC   The Nasdaq Capital Market
Preferred Stock, $0.001 par value   CYCCP   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 2, 2025, Cyclacel Pharmaceuticals, Inc. (the “Company”) filed an amendment to its Certificate of Incorporation (“Certificate of Amendment”) to implement a one-for-fifteen reverse stock split. The effective date of the Certificate of Amendment is July 7, 2025 (the “Effective Date”). The Company’s common stock will begin trading on a split-adjusted basis when the market opens on the Effective Date. The Board of Directors of the Company approved the amendment to the Company’s Certificate of Incorporation primarily to meet the share bid price requirements of The Nasdaq Capital Market. The Company’s stockholders approved the Certificate of Amendment by majority written consent on May 12, 2025.

 

As a result of the reverse stock split, on the Effective Date, every fifteen shares of common stock then issued and outstanding automatically will be combined into one share of common stock, with no change in par value per share. No fractional shares will be outstanding following the reverse stock split, and any fractional shares that would have resulted from the reverse stock split will be (a) rounded up to the nearest whole number for any shareholder who would otherwise be entitled to receive one-half or more of a fractional split-adjusted share, and (b) rounded down to the nearest whole number for any shareholder who would otherwise be entitled to receive less than one-half of a fractional split-adjusted share.

 

The text of the Certificate of Amendment of the Certificate of Incorporation of the Company that effected the foregoing actions is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

The trading symbol for the Company’s common stock will remain “CYCC.” The Company was assigned a new CUSIP number (23254L876) in connection with the reverse split. All options, warrants and other convertible securities of the Company outstanding immediately prior to the effectiveness of the Certificate of Amendment will be adjusted in accordance with the terms of the plans, agreements or arrangements governing such options, warrants and other convertible securities and subject to rounding to the nearest whole share.

 

Item 7.01 Regulation FD Disclosure

 

On July 2, 2025, the Company issued a press release announcing the reverse stock split. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information set forth in Item 7.01 of this report shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any of the Company’s filings with the Securities and Exchange Commission under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
3.1   Certificate of Amendment to Certificate of Incorporation, effective July 7, 2025
99.1   Press Release dated July 2, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 2, 2025 Cyclacel Pharmaceuticals, Inc.
     
  By: /s/ Datuk Dr. Doris Wong Sing Ee
  Name: Datuk Dr. Doris Wong Sing Ee
  Title: Chief Executive Officer

 

3

 

 

FAQ

How many PESI shares did Director Zach Wamp purchase on July 1, 2025?

He purchased 1,153 common shares.

What was the purchase price of the PESI shares?

The reported price was $7.89 per share.

How many PESI shares does Zach Wamp own after the transaction?

His direct beneficial ownership rose to 49,365 shares.

What SEC form disclosed this insider activity for PESI?

The transaction was reported on Form 4 filed on July 2, 2025.

Is Zach Wamp an officer or director of Perma-Fix Environmental Services?

He is listed as a Director of the company.
Cyclacel Phar Pr

NASDAQ:CYCCP

CYCCP Rankings

CYCCP Latest News

CYCCP Latest SEC Filings

CYCCP Stock Data

8.54M
333.67k
1.18%
15.03%
Biotechnology
Pharmaceutical Preparations
Malaysia
BERKELEY HEIGHTS